Rana Sanyal
CSO and Co-Founder : RS Research and PDC Therapeutics
Turkey
Rana Sanyal, Chief Scientific Officer and Co-Founder of RS Research and PDC Therapeutics, has been awarded the EU Prize for Women Innovators 2023-24. Her pioneering work in developing advanced cancer treatments, specifically smart nanomedicines for targeted chemotherapy, significantly improves treatment efficacy and safety. Sanyal’s contributions to biomedical research position her as a leading figure driving transformative advancements in oncology and biotechnology.
| Total Patents | 49 |
| Granted Patents | 22 |
| Associated Companies | Amgen Inc., RS Research, PDC Therapeutics |
| Field of Invention | Drug Delivery Systems |
Rana Sanyal’s portfolio has 49 patents belonging to 49 unique patent families. Her patents belong to technological domains such as Polymer drug conjugates and Drug delivery systems.
Join us in this venture to uncover the diverse technological areas Rana Sanyal has patented inventions in. This article also discloses the patent filing trend, worldwide filing and research centers along with several other insights mined through the patent data set for the renowned inventor.
The data of inventors patents made available here is solely intended for informational purposes. Although we make every effort to maintain the accuracy and comprehensiveness of the provided information, we cannot guarantee that all data is completely free of errors or entirely up-to-date. If you happen to be the Inventor and wish to contribute additional data for your respective portfolio, kindly get in touch with us.
How Many Patents did Rana Sanyal File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Rana Sanyal Applications Filed | Rana Sanyal Patents Granted |
| 2024 | – | 5 |
| 2023 | 2 | 12 |
| 2022 | 3 | 4 |
| 2021 | 1 | 1 |
| 2020 | 3 | – |
| 2019 | 7 | – |
| 2018 | 2 | – |
| 2017 | 29 | – |
| 2016 | 2 | – |
How Many Rana Sanyal patents are Alive/Dead?
Worldwide Patents
How Many Patents did Rana Sanyal File in Different Countries?
Countries in which Rana Sanyal Filed Patents
| Country | Patents |
| Europe (EPO) | 5 |
| Korea (South) | 5 |
| Mexico | 3 |
| United States of America | 3 |
| Australia | 3 |
| Spain | 2 |
| Finland | 2 |
| United Kingdom | 2 |
| Hungary | 2 |
| Poland | 2 |
| Canada | 2 |
| Turkey | 2 |
| Israel | 2 |
| Brazil | 2 |
| Croatia | 2 |
| Denmark | 2 |
| India | 2 |
| Japan | 1 |
| Eurasian Patent Organization | 1 |
Which Technologies are covered by Rana Sanyal’s Patents?
Our analysis of the Rana Sanyal patent portfolio revealed that she does not own any design patents. However, her patents span across the given technological domains related to biomedical research as illustrated in the chart below.
We also came across few intriguing inventions in the Rana Sanyal patent portfolio. Read the summary of these ingenious innovations that showcase the incredible inventions of Rana Sanyal’s technological ventures.
Antibody-polymer conjugates revolutionize targeted drug delivery by offering higher drug capacity and improved solubility.
The patent, US20220152216A1, discloses the combination of these innovative conjugates with an antibody with a specially designed polymer, featuring a methacrylate backbone and polyethylene glycol (PEG) branches. Drugs are attached to the polymer through cleavable bonds, ensuring they are released precisely within the tumor. The PEG side chains enhance solubility, making the conjugates more effective and efficient than traditional methods. This smart design allows for high drug loading and active targeting, significantly advancing cancer treatment.
The patent, US20190321479A1, features polymer drug conjugates with a (meth)acrylate backbone and two types of side chains: a PEG chain for stability and another side chain that carries a therapeutic agent via a breakable linker. It outlines the process for creating these conjugates and highlights their potential in treating diseases like cancer.
Well, this sums up the interesting summaries of the fascinating patents we discovered during our analysis. Keep reading to get more informative insights we mined through the Rana Sanyal patent portfolio.
Best Rana Sanyal Patent
US20190321479A1 is the most popular patent in Rana Sanyal’s portfolio. It has received 11 citations so far from companies like Kodiak Sciences, Starpharma and Sichuan Yingrui Pharmaceutical Technology Co., Ltd.
What are Rana Sanyal key innovation segments?
What Technologies are Covered by Rana Sanyal?
The chart below distributes patents filed by Rana Sanyal in different countries on the basis of the technology protected in patents. It also represents the markets where Rana Sanyal thinks it’s important to protect particular technology inventions.
R&D Focus: How has Rana Sanyal search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Rana Sanyal?